The Effectiveness of Home Blood Pressure Telemonitoring with Telemedicine Follow-Up in Improving Hypertension Control Among US Adults
Overview
This quasi-experimental study evaluates the effectiveness of home blood pressure telemonitoring combined with telemedicine follow-up versus standard in-person care for hypertension management in US adults aged 40-75. The intervention group receiving remote monitoring and virtual visits demonstrated significantly better blood pressure control rates (approximately 65%) and higher medication adherence compared to the control group (35% control rate). The findings suggest that integrated digital health interventions can reduce health disparities and improve hypertension outcomes while aligning with current AHA/ACC guidelines.
What this research paper covers
- Abstract: Study design, methodology, and key findings on intervention effectiveness
- Research Background: Hypertension prevalence, burden, and current control rates in US populations
- Study methodology: Quasi-experimental design with 300 stratified participants comparing intervention and control groups over 12 months
Preview
The Effectiveness of Home Blood Pressure Telemonitoring with Telemedicine Follow-Up in Improving Hypertension Control Among US Adults
Student Name
Institution Name
Course Name
Professor Name
Due Date
Abstract
Hypertension affects millions of US adults and remains a leading modifiable risk factor for cardiovascular disease (CVD), stroke, and kidney disease. Despite national guidelines, control rates hover around 20 to 25%, with persistent disparities by age, sex, race, ethnicity, and access to care. This hypothetical quasi-experimental study evaluated the effectiveness of a combined home blood pressure (BP) telemonitoring and telemedicine follow-up intervention versus standard in-person care in improving hypertension control and adherence among US adults aged 40 to 75 with diagnosed hypertension. The purpose was to assess whether remote monitoring and virtual visits could address barriers such as inconsistent monitoring and limited access. A convenience sample of 300 participants was stratified by demographics and assigned to intervention (n=150) or control (n=150) groups. The intervention included Bluetooth-enabled home BP monitors with app-based data upload and monthly telemedicine visits for medication adjustment and education over 12 months. Data collection involved office and home BP measurements, adherence surveys, and self-efficacy scales at baseline, 3, 6, and 12 months. The results demonstrated significant improvements in the intervention group. The control group showed only a 4 mm Hg reduction and 35% control rate. Adherence and self-efficacy scores were also higher in the intervention arm, with greater benefits observed among older and rural participants.